{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T23:08:50Z","timestamp":1789427330379,"version":"build-2803163510"},"reference-count":55,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Primary Care: Clinics in Office Practice"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1016\/j.pop.2010.11.005","type":"journal-article","created":{"date-parts":[[2010,12,25]],"date-time":"2010-12-25T10:03:41Z","timestamp":1293271421000},"page":"59-70","source":"Crossref","is-referenced-by-count":11,"title":["Opioid Dependence"],"prefix":"10.1016","volume":"38","author":[{"suffix":"III","given":"Joseph J.","family":"Benich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.pop.2010.11.005_bib1","first-page":"1573","article-title":"Managing opioid addiction with buprenorphine","volume":"73","author":"Donaher","year":"2006","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.pop.2010.11.005_bib2","first-page":"2404","article-title":"Methadone therapy for opioid dependence","volume":"63","author":"Krambeer","year":"2001","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.pop.2010.11.005_bib3","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1001\/archpsyc.1997.01830130077015","article-title":"Psychiatric and substance use comorbidity among treatment-seeking opioid abusers","volume":"54","author":"Brooner","year":"1997","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pop.2010.11.005_bib4","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1097\/00002508-200207001-00003","article-title":"Assessment and treatment of comorbid psychiatric disorders in opioid-dependent patients","volume":"18","author":"Strain","year":"2002","journal-title":"Clin J Pain"},{"key":"10.1016\/j.pop.2010.11.005_bib5","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1177\/070674370605101003","article-title":"Evidence-based treatment of opioid-dependent patients","volume":"51","author":"Van de Brink","year":"2006","journal-title":"Canada Journal of Psychiatry"},{"key":"10.1016\/j.pop.2010.11.005_bib6","series-title":"Relapse prevention: maintenance strategies in the treatment of addictive behaviors","first-page":"151","article-title":"Relapse prevention for opioid dependence","author":"Haug","year":"2005"},{"key":"10.1016\/j.pop.2010.11.005_bib7","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0376-8716(00)00162-9","article-title":"The economic costs of heroin addiction in the United States","volume":"61","author":"Mark","year":"2001","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.pop.2010.11.005_bib9","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.pbb.2006.10.015","article-title":"Differential involvement of endogenous opioids in sucrose consumption and food reinforcement","volume":"85","author":"Hayward","year":"2006","journal-title":"Pharmacol Biochem Behav"},{"issue":"2","key":"10.1016\/j.pop.2010.11.005_bib10","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.biopsych.2008.09.009","article-title":"Delta-opioid receptor antagonists prevent sensitization to the conditioned rewarding effects of morphine","volume":"65","author":"Shippenberg","year":"2009","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pop.2010.11.005_bib11","series-title":"Goodman and Gilman\u2019s the pharmacological basis of therapeutics","first-page":"485","article-title":"Opioid analgesics and antagonists","author":"Jaffe","year":"1990"},{"key":"10.1016\/j.pop.2010.11.005_bib12","series-title":"Goodman and Gilman\u2019s the pharmacological basis of therapeutics","first-page":"311","article-title":"General anesthetics","author":"Marshall","year":"1990"},{"key":"10.1016\/j.pop.2010.11.005_bib13","series-title":"Substance abuse a comprehensive textbook","first-page":"186","article-title":"Opiates: clinical aspects","author":"Jaffe","year":"1992"},{"key":"10.1016\/j.pop.2010.11.005_bib14","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1038\/sj.npp.1301263","article-title":"There and back again: a tale of norepinephrine and drug addiction","volume":"32","author":"Weinshenker","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pop.2010.11.005_bib15","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1146\/annurev.ne.19.030196.001535","article-title":"Addictive drugs and brain stimulation reward","volume":"19","author":"Wise","year":"1996","journal-title":"Annu Rev Neurosci"},{"key":"10.1016\/j.pop.2010.11.005_bib16","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.brainresrev.2008.03.002","article-title":"Cellular and molecular mechanisms involved in the neurotoxicity of opioid and psychostimulant drugs","volume":"58","author":"Cunha-Oliveira","year":"2008","journal-title":"Brain Res Rev"},{"key":"10.1016\/j.pop.2010.11.005_bib17","series-title":"Principles of addiction medicine","first-page":"131","article-title":"The pharmacology of opioids","author":"Gold","year":"1998"},{"key":"10.1016\/j.pop.2010.11.005_bib18","series-title":"New treatements for opiate dependence","first-page":"286","article-title":"Basic neurobiology of opiate addiction","author":"Nestler","year":"1997"},{"key":"10.1016\/j.pop.2010.11.005_bib19","series-title":"The treatment of opioid dependence","author":"Strain","year":"2006"},{"key":"10.1016\/j.pop.2010.11.005_bib20","series-title":"Pharmacology of buprenorphine. The treatment of opioid dependence","author":"Strain","year":"2006"},{"key":"10.1016\/j.pop.2010.11.005_bib21","doi-asserted-by":"crossref","first-page":"225","DOI":"10.36076\/ppj.2008\/11\/225","article-title":"Opioid antagonists, partial agonists and agonists\/antagonists: the role of office-based detoxification","volume":"11","author":"Helm","year":"2008","journal-title":"Pain Physician"},{"key":"10.1016\/j.pop.2010.11.005_bib22","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/sj.bjp.0706661","article-title":"Differential activation of G-proteins by mu-opioid receptor agonists","volume":"147","author":"Saidak","year":"2006","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pop.2010.11.005_bib23","series-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"1994"},{"key":"10.1016\/j.pop.2010.11.005_bib24","series-title":"Harrison\u2019s principles of internal medicine","first-page":"2567","article-title":"Opioid drug abuse and dependence","author":"Schuckit","year":"2005"},{"key":"10.1016\/j.pop.2010.11.005_bib25","series-title":"Principles of addiction medicine","first-page":"457","article-title":"Management of opioid intoxication and withdrawal","author":"O\u2019Connor","year":"1998"},{"key":"10.1016\/j.pop.2010.11.005_bib26","article-title":"Methadone at tapered doses for the management of opioid withdrawal","volume":"3","author":"Amato","year":"2002","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.pop.2010.11.005_bib27","series-title":"The treatment of opioid dependence","first-page":"346","article-title":"Medically supervised withdrawal as stand-alone treatment","author":"Gossop","year":"2006"},{"key":"10.1016\/j.pop.2010.11.005_bib28","first-page":"83","article-title":"Doing methadone right","volume":"123","author":"Nadelmann","year":"1996","journal-title":"Public Interest"},{"key":"10.1016\/j.pop.2010.11.005_bib29","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1001\/jama.279.3.229","article-title":"Rapid and ultrarapid opioid detoxification techniques","volume":"279","author":"O\u2019Connor","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.pop.2010.11.005_bib30","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1097\/00003246-200004000-00010","article-title":"Acute detoxification of opioid-addicted patients with naloxone during propofol or methohexital anesthesia: a comparison of withdrawal symptoms, neuroendocrine, metabolic, and cardiovascular patterns","volume":"28","author":"Kienbaum","year":"2000","journal-title":"Crit Care Med"},{"key":"10.1016\/j.pop.2010.11.005_bib31","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1197\/aemj.9.1.63","article-title":"Complications of ultrarapid opioid detoxification with subcutaneous naltrexone pellets","volume":"9","author":"Hamilton","year":"2002","journal-title":"Acad Emerg Med"},{"key":"10.1016\/j.pop.2010.11.005_bib32","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1001\/jama.294.8.903","article-title":"Anesthesia-assisted vs buprenorphine- or clonidine-assisted heroin detoxification and naltrexone induction: a randomized trial","volume":"294","author":"Collins","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.pop.2010.11.005_bib33","article-title":"Opioid antagonists under heavy sedation or anesthesia for opioid withdrawal","volume":"1","author":"Gowing","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.pop.2010.11.005_bib34","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD005031","article-title":"Psychosocial and pharmacological treatments versus pharmacological treatments for opioid detoxification","volume":"4","author":"Amato","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.pop.2010.11.005_bib37","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1046\/j.1360-0443.2003.00354.x","article-title":"Does retention mater? Treatment duration and improvement in drug use","volume":"98","author":"Zhang","year":"2003","journal-title":"Addiction"},{"key":"10.1016\/j.pop.2010.11.005_bib38","article-title":"Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence","volume":"2","author":"Mattick","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.pop.2010.11.005_bib39","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/S0140-6736(03)12600-1","article-title":"1-year retention and social function after buprenorphine assisted relapse prevention treatment for heroin dependence in Sweden: a randomized, placebo-controlled trial","volume":"361","author":"Kakko","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.pop.2010.11.005_bib40","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1001\/jama.286.14.1724","article-title":"Methadone maintenance in primary care: a randomized controlled trial","volume":"286","author":"Fiellin","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.pop.2010.11.005_bib41","article-title":"Methadone maintenance at different dosages for opioid dependence","volume":"3","author":"Faggiano","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.pop.2010.11.005_bib42","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s11606-006-0258-x","article-title":"Brief report: methadone treatment of injecting opioid users for prevention of HIV infection","volume":"21","author":"Gowing","year":"2006","journal-title":"J\u00a0Gen Intern Med"},{"key":"10.1016\/j.pop.2010.11.005_bib43","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1002\/pds.1112","article-title":"QT prolongation and torsades de pointes among methadone users: reports to the FDA spontaneous reporting system","volume":"14","author":"Pearson","year":"2005","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.pop.2010.11.005_bib44","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.amjmed.2007.10.009","article-title":"A\u00a0community-based evaluation of sudden death associated with therapeutic levels of methadone","volume":"121","author":"Chugh","year":"2008","journal-title":"Am J Med"},{"key":"10.1016\/j.pop.2010.11.005_bib45","doi-asserted-by":"crossref","first-page":"387","DOI":"10.7326\/0003-4819-150-6-200903170-00103","article-title":"QTc interval screening in methadone treatment","volume":"150","author":"Krantz","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.pop.2010.11.005_bib46","article-title":"Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence","volume":"2","author":"Mattick","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.pop.2010.11.005_bib47","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1007\/s11606-006-0050-y","article-title":"Patient satisfaction with primary care office-based buprenorphine\/naloxone treatment","volume":"22","author":"Barry","year":"2007","journal-title":"J\u00a0Gen Intern Med"},{"key":"10.1016\/j.pop.2010.11.005_bib48","series-title":"Methadone and buprenorphine for the management of opioid dependence","author":"National Institute for Health and Clinical Excellence (NICE)","year":"2007"},{"key":"10.1016\/j.pop.2010.11.005_bib49","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1046\/j.1360-0443.1999.94913376.x","article-title":"Buprenorphine versus methadone maintenance for the treatment of opioid dependence","volume":"94","author":"Fischer","year":"1999","journal-title":"Addiction"},{"key":"10.1016\/j.pop.2010.11.005_bib50","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1001\/archpsyc.1997.01830200041006","article-title":"Buprenorphine vs methadone maintenance treatment for concurrent opioid dependence and cocaine abuse","volume":"54","author":"Schottenfeld","year":"1997","journal-title":"Arch gen psychiatry"},{"key":"10.1016\/j.pop.2010.11.005_bib51","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1136\/bmj.331.7529.1352","article-title":"Is methadone too dangerous for opiate addiction?","volume":"331","author":"Luty","year":"2005","journal-title":"BMJ"},{"key":"10.1016\/j.pop.2010.11.005_bib52","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.cnr.2005.08.012","article-title":"Recent advances in the treatment of opiate addiction","volume":"6","author":"Ling","year":"2005","journal-title":"Clin Neurosci Res"},{"key":"10.1016\/j.pop.2010.11.005_bib53","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.drugalcdep.2008.07.013","article-title":"Cost analysis of clinic and office-based treatment of opioid dependence: results with methadone and buprenorphine in clinically stable patients","volume":"99","author":"Jones","year":"2009","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.pop.2010.11.005_bib54","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1111\/j.1525-1497.2005.0228.x","article-title":"Buprenorphine retention in primary care","volume":"20","author":"Stein","year":"2005","journal-title":"J\u00a0gen intern med"},{"key":"10.1016\/j.pop.2010.11.005_bib55","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004147.pub3","article-title":"Psychosocial combined with agonist maintenance treatments versus agonist maintenance treatments alone for treatment of opioid dependence","volume":"4","author":"Amato","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.pop.2010.11.005_bib56","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0376-8716(95)01103-6","article-title":"Drug users\u2019 spiritual beliefs, locus of control and the disease concepts in relation to Narcotics Anonymous attendance and six-month outcomes","volume":"38","author":"Christo","year":"1995","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.pop.2010.11.005_bib57","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/j.2044-8260.1994.tb01111.x","article-title":"Anxiety and self-esteem as a function of abstinence time among recovering addicts attending Narcotics Anonymous","volume":"33","author":"Christo","year":"1994","journal-title":"Br J Clin Psychol"},{"issue":"1","key":"10.1016\/j.pop.2010.11.005_bib58","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1360-0443.2007.02050.x","article-title":"Attendance at Narcotics Anonymous and Alcoholics Anonymous meetings, frequency of attendance and substance use outcomes after residential treatment for drug dependence: a 5-year follow-up study","volume":"103","author":"Gossop","year":"2008","journal-title":"Addiction"}],"container-title":["Primary Care: Clinics in Office Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0095454310000977?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0095454310000977?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,11,16]],"date-time":"2021-11-16T08:12:34Z","timestamp":1637050354000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0095454310000977"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["S0095454310000977"],"URL":"https:\/\/doi.org\/10.1016\/j.pop.2010.11.005","relation":{},"ISSN":["0095-4543"],"issn-type":[{"value":"0095-4543","type":"print"}],"subject":[],"published":{"date-parts":[[2011,3]]}}}